[1]李晋生,陈霞,靳冉,等.活血化瘀中药干预兔动脉粥样硬化形成作用研究[J].中国中医药信息杂志,2012,19(4):35-37.[doi:10.3969/j.issn.1005-5304.2012.04.013]
 LI Jin-sheng,CHEN Xia,JIN Ran,et al.Anti-atherosclerosis Effects of Traditional Chinese Medicines with Activating Blood Circulation to Dissipate Blood Stasis Function[J].zhongguo zhongyiyao xinxi zazhi,2012,19(4):35-37.[doi:10.3969/j.issn.1005-5304.2012.04.013]
点击复制

活血化瘀中药干预兔动脉粥样硬化形成作用研究

参考文献/References:

[1] 邵明义,施斌,郑玉.痰瘀同治法在高脂血症治疗中的应用[J].河南中医,2005,25(3):59-60.

[2] 马希英,李军.高脂血症从瘀论治四法[J].吉林中医药,2004,24(11):16-17.

[3] 徐叔云,卞如濂.药理实验方法学[M].3版.北京:人民卫生出版社,2003:1202.

[4] Orem C, Orem A, Uydu HA, et al. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies:relationship with low-density lipoprotein oxidation and plasma total antioxidant status[J]. Coron Artery Dis,2002,13(1):65-71.

[5] 李芹,荆清.一氧化氮和氧化低密度脂蛋白相互作用及其与动脉粥样硬化的关系[J].国外医学:心血管疾病分册,1999,26(1):23-24.

[6] 蔡海江.动脉粥样硬化的基础与临床[M].南京:江苏科学技术出版社, 1999:161-163.

[7] Lacoste L, Lam JY, Hung J, et al. Hyperlipidemia and coronary disease:correlation of the increased thrombogenic potential with cholesterol reduction[J]. Circulation,1995,92(11):3172-3177.

[8] 孙立涛,田家玮,马娜.多普勒超声对兔动脉硬化的血流动力学与流变学研究[J].中国医学影像技术,2005,21(6):843-845.

[9] 王玉萍,路浩,徐岷.动脉粥样硬化性缺血性脑卒中血液流变学及相关危险因素[J].中国实用神经疾病杂志,2007,10(3):75-76.

[10] 王进,董长林,冯娜,等.冠心病患者颈动脉斑块形成与血液流变学指标关系的探讨[J].国际检验医学杂志,2009,30(4):382-386.

[11] 于俊生,陈兆昌.动脉粥样硬化从痰瘀毒论治探讨[J].山东中医杂志, 2002,21(8):451-452.

[12] 孔祥明.活血化瘀药对动脉粥样硬化形成机制的干预[J].国外医学:中医中药分册,2002,24(4):195-198.

[13] 蔡大勇,梅家俊,陈振发,等.川芎调节血脂防治家兔动脉粥样硬化症的研究[J].湖北中医杂志,2001,23(10):3-5.

[14] 彭小春,马红莺,尹刚,等.川芎嗪抗动脉粥样硬化机制的研究[J].时珍国医国药,2010,21(5):1130-1131.

相似文献/References:

[1]张 薇,邹兆重,刘慧珍,等.微波干燥丹参药材及其质量评价研究[J].中国中医药信息杂志,2010,17(12):36.[doi:10.3969/j.issn.1005-5304.2010.12.015]
 ZHANG Wei,ZOU Zhao-zhong,LIU Hui-zhen,et al.Study on Microwave Drying of Salvia miltiorrhiza Bunge and Evaluation of Its Quality[J].zhongguo zhongyiyao xinxi zazhi,2010,17(4):36.[doi:10.3969/j.issn.1005-5304.2010.12.015]
[2]朱金墙,闫 晨,康立源.丹酚酸B的稳定性及其降解机理研究进展[J].中国中医药信息杂志,2010,17(12):113.[doi:10.3969/j.issn.1005-5304.2010.12.060]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(4):113.[doi:10.3969/j.issn.1005-5304.2010.12.060]
[3]尹苗,冯成强.丹参活性成分抗动脉粥样硬化机理研究进展[J].中国中医药信息杂志,2009,16(7):100.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(4):100.
[4]谭毅,黄伟,张学英.男科疾病瘀血证中医治疗配伍九法[J].中国中医药信息杂志,2009,16(6):89.
[5]李敏,李锋,胡波,等.丹参对内毒素致急性肺损伤大鼠肺水通道蛋白-1的调节效应[J].中国中医药信息杂志,2007,14(3):30.
 LI Min,LI Feng,HU Bo,et al.Effect of Salvia Miltiorrhiza on Aquaporin-1 Expression in Rats Model of Lipopolysaccharide- induced Acute Lung Injury[J].zhongguo zhongyiyao xinxi zazhi,2007,14(4):30.
[6]杨晖,何银辉,李向荣,等.早期运用活血化瘀法治疗出血性中风临床观察[J].中国中医药信息杂志,2007,14(3):61.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(4):61.
[7]胡东鹏.风药亦为活血药谈[J].中国中医药信息杂志,2011,18(3):102.[doi:10.3969/j.issn.1005-5304.2011.03.052]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):102.[doi:10.3969/j.issn.1005-5304.2011.03.052]
[8]李曼玲,冯伟红,康琛,等.丹参药材水溶性成分含量的HPLC法分析[J].中国中医药信息杂志,2008,15(8):49.
 LI Man-ling,FENG Wei-hong,KANG Chen,et al.Determination of Water Soluble Components in Salvia miltiorrhiza Bge. by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):49.
[9]齐元富,李秀荣,李慧杰.大黄?虫丸治疗肺癌临床研究[J].中国中医药信息杂志,2011,18(11):15.[doi:10.3969/j.issn.1005-5304.2011.11.006]
 QI Yuan-fu,LI Xiu-rong,LI Hui-jie.Clinical Study on Lung Cancer Treated by Dahuang Zhechong Wan[J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):15.[doi:10.3969/j.issn.1005-5304.2011.11.006]
[10]张永太,修彦凤,陶建生,等.黄芪、丹参、三七中多糖提取工艺考察[J].中国中医药信息杂志,2011,18(11):65.[doi:10.3969/j.issn.1005-5304.2011.11.026]
 ZHANG Yong-tai,XIU Yan-feng,TAO Jian-sheng,et al.Extraction of Crude Polysaccharide from Radix astragali, Radix salviae miltiorrhizae and Radix notoginseng[J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):65.[doi:10.3969/j.issn.1005-5304.2011.11.026]

备注/Memo

基金项目:中医药行业科研专项(200707012);“重大新药创制”国家科技重大专项(2009ZX09311)

更新日期/Last Update: